Scientific Symposium 2012

This annual one-day scientific gathering of industry professionals and researchers will be held on Wednesday, September 26, 2012 at the MMS global headquarters in Canton, Michigan.

The complimentary event is open to all individuals in the pharmaceutical and biotech arenas. Registration is currently open and limited to the first 150 registrants. Presenters for the symposium include some of the top innovators in pharma. Presentations include:

 -Challenges in Conducting Pain Trials: A Sponsor’s Perspective by Nico Merante, MD, Senior Director of Clinical Development at Daiichi Sankyo Development Ltd. 

-Quantitative Decision Making: No Longer a Simple Yes or No Question by Kevin Chartier, Ph.D., Global Franchise Head at Novartis Pharmaceuticals Corporation. 

-Trends, Needs and Next Steps in the Evolving Regulations of Clinical Trial Disclosures by Joe Archer, Associate Director, Disclosure Services at MMS Holdings Inc. 

-Regulatory Mechanisms to Speed Access to Medicines: A Worldwide Overview by Mark Ammann, Pharm.D., and Lisa Rysso-DeMaggio, Regulatory Strategy for MMS Holdings Inc.

To register go to: http://blog.mmsholdings.com/annual-scientific-symposium-2012